Premium
Deep vein thrombosis and lung cancer in a patient with psoriasis under anti‐tumor necrosis factor treatment: a case study
Author(s) -
Tatarkova Iva,
Cetkovska Petra
Publication year - 2013
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12041
Subject(s) - medicine , etanercept , psoriasis , deep vein , thrombosis , adverse effect , lung cancer , cancer , observational study , tumor necrosis factor alpha , surgery , venous thrombosis , pulmonary embolism , dermatology
We describe a case of a patient with severe generalized psoriasis treated with etanercept, who developed deep vein thrombosis and 1 year later developed solid lung cancer. Anti‐tumor necrosis factor therapies have been a powerful addition to the therapy of psoriasis; nevertheless, the treatment might be associated with adverse events, such as venous thromboembolism or malignancies. Available data regarding these specific adverse reactions are rather conflictive; therefore, more observational studies and registry reports for long‐term risk assessment are needed.